CIK 0001553643
- Non-accelerated filer
- Smaller reporting company
RELMADA THERAPEUTICS, INC.
Sign in to watch- Ticker
- RLMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 455401931
- Phone
- +1 646-876-3459
- Business address
- 2222 PONCE DE LEON BLVD. 3RD FLOOR, CORAL GABLES, FL, 33134
- Former names
- CAMP NINE, INC.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 10,000 shares at $30.04 ($300,395)
- 4 Open-market sale Director sold 19,800 shares at $29.00 ($574,200)
- 4 Exercise or conversion Director acquired 20,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 6,600 shares at $29.00 ($191,400)
- 4 Exercise or conversion Director acquired 10,000 shares (option exercise)
- 4 Open-market sale Director sold 3,300 shares at an average $31.54 ($104,088)
- 4/A Insider Changes in Ownership
- 4 Open-market sale Director sold 3,000 shares at an average $33.34 ($100,020)
- 4 Open-market sale Director sold 3,000 shares at $38.22 ($114,647)
- 4 Open-market sale Director sold 3,000 shares at an average $35.43 ($106,281)
- 4 Open-market sale CEO sold 10,000 shares at an average $35.48 ($354,845)
Page 5 of 10 · 200 filings